News stories about Neogen (NASDAQ:NEOG) have trended somewhat positive on Saturday, according to Accern Sentiment. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Neogen earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 44.3990138721477 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Several brokerages have weighed in on NEOG. Zacks Investment Research lowered shares of Neogen from a “buy” rating to a “hold” rating in a research note on Wednesday, December 6th. BidaskClub raised shares of Neogen from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Stephens reaffirmed a “hold” rating and set a $62.00 target price on shares of Neogen in a research note on Wednesday, January 10th. Roth Capital set a $62.00 target price on shares of Neogen and gave the stock a “hold” rating in a research note on Thursday, January 4th. Finally, Craig Hallum increased their target price on shares of Neogen from $46.50 to $60.00 and gave the stock a “hold” rating in a research note on Thursday, December 7th. Five investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $63.25.
Neogen (NEOG) opened at $64.31 on Friday. The firm has a market cap of $3,288.17, a PE ratio of 63.99, a price-to-earnings-growth ratio of 3.95 and a beta of 1.42. Neogen has a 12 month low of $44.63 and a 12 month high of $64.57.
Neogen (NASDAQ:NEOG) last announced its earnings results on Wednesday, January 3rd. The company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.07. The company had revenue of $101.80 million during the quarter, compared to analyst estimates of $102.46 million. Neogen had a net margin of 13.47% and a return on equity of 10.72%. Neogen’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.29 earnings per share. analysts predict that Neogen will post 1.08 earnings per share for the current fiscal year.
In other news, CFO Steven J. Quinlan sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $60.15, for a total value of $120,300.00. Following the completion of the transaction, the chief financial officer now owns 15,470 shares of the company’s stock, valued at $930,520.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider James L. Herbert sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $57.50, for a total transaction of $575,000.00. Following the completion of the transaction, the insider now directly owns 1,163,755 shares of the company’s stock, valued at approximately $66,915,912.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 66,382 shares of company stock valued at $3,939,913. 4.20% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: “Neogen (NEOG) Getting Somewhat Positive Press Coverage, Report Finds” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/03/17/neogen-neog-getting-somewhat-positive-press-coverage-report-finds.html.
Neogen Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.